← Back to Search

Non-Invasive Spinal Cord Stimulation for Neurological Disorders

N/A
Recruiting
Led By Katherine M Steele, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients who can walk 20 yards, with or without an assistive device
Must not have
Patients with unhealed fracture or other musculoskeletal impairment that might interfere with lower extremity rehabilitation or testing activities
Patients with active cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 10 months.
Awards & highlights
No Placebo-Only Group

Summary

This trial will study whether non-invasive stimulation of the spinal cord can improve walking function for people with neurologic conditions.

Who is the study for?
This trial is for people with neurological conditions like cerebral palsy who can walk 20 yards and follow simple instructions. They must be medically stable, able to attend up to five therapy sessions weekly, and have support for the 11-month study period. Those with severe medical issues, uncontrolled seizures, recent musculoskeletal surgeries, or implanted devices are excluded.
What is being tested?
The study tests if non-invasive spinal stimulation combined with gait training improves walking in neurologic conditions. It's a cross-over design where participants first get only training or training plus stimulation, then switch after a break period. Each phase lasts up to 8 weeks with follow-ups for three months.
What are the potential side effects?
Potential side effects of transcutaneous spinal stimulation may include discomfort at the site of stimulation, muscle spasms, skin irritation from electrode placement, and fatigue due to increased physical activity during gait training.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can walk 20 yards with or without help.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I don't have any unhealed fractures or conditions that would stop me from doing leg exercises.
Select...
My cancer is currently active.
Select...
I have a heart or muscle condition that stops me from fully joining in physical therapy.
Select...
I have a history of seizures that are not well-controlled.
Select...
I do not have uncontrolled high blood pressure or serious heart, lung, or blood clotting issues.
Select...
I have a rheumatic disease like rheumatoid arthritis or lupus.
Select...
I haven't had leg or back surgery in the past year that could affect study results.
Select...
I am taking medication for my diagnosed osteoporosis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 10 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 10 months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from baseline - Six Minute Walk Test
Change from baseline - Ten Meter Walk Test
Secondary study objectives
Change from baseline - Electromyography recording of lower extremity muscles
Change from baseline - Gait Outcomes Assessment List
Change from baseline - Kinetic and kinematic gait analysis using three dimensional camera system
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Intensive Training OnlyActive Control1 Intervention
Physical and gait training that targets rehabilitation of walking function.
Group II: Intensive Training Combined with Spinal StimulationActive Control2 Interventions
Transcutaneous spinal stimulation combined with physical and gait training that targets rehabilitation of walking function.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,829 Previous Clinical Trials
1,907,074 Total Patients Enrolled
10 Trials studying Cerebral Palsy
1,185 Patients Enrolled for Cerebral Palsy
Seattle Children's HospitalOTHER
310 Previous Clinical Trials
5,231,560 Total Patients Enrolled
7 Trials studying Cerebral Palsy
211 Patients Enrolled for Cerebral Palsy
Katherine M Steele, PhDPrincipal InvestigatorUniversity of Washington
2 Previous Clinical Trials
91 Total Patients Enrolled
2 Trials studying Cerebral Palsy
91 Patients Enrolled for Cerebral Palsy

Media Library

Cerebral Palsy Clinical Trial 2023: Gait Training Highlights & Side Effects. Trial Name: NCT04467437 — N/A
~6 spots leftby Aug 2026